Patient-nephrologist prognostic awareness and discordance in end stage renal disease on renal replacement therapy

被引:0
|
作者
Sassine Ghanem
Sami Hossri
Nicholas Fuca
Evgenia Granina
Samer Saouma
Frank Forte
机构
[1] SUNY Downstate Medical Center,Department of Hematology and Medical Oncology
[2] Northwell Health - Staten Island University Hospital,Department of Pulmonary and Critical Care
[3] Mount Sinai,Department of Nephrology
[4] Virginia Commonwealth University,Department of Hospice and Palliative Care Medicine
[5] Northwell Health - Staten Island University Hospital,Department of Cardiology
[6] Northwell Health - Staten Island University Hospital,Department of Hospice and Palliative Care Medicine
来源
关键词
Prognosis; End stage renal disease; Quality of life; Hemodialysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:765 / 773
页数:8
相关论文
共 50 条
  • [31] Enzyme replacement therapy in patients with Fabry disease and end-stage renal disease
    Nature Clinical Practice Nephrology, 2007, 3 (10): : 525 - 526
  • [32] Factors predicting survival during replacement therapy for end stage renal disease
    Corte, CD
    Ortega, F
    Rebollo, P
    Baltar, JM
    Alvarez, R
    Alvarez-Ude, F
    Badía, X
    Fernández, E
    Rodríguez, M
    Grande, JA
    NEFROLOGIA, 1999, 19 (03): : 244 - 253
  • [33] Testosterone metabolism and replacement therapy in patients with end-stage renal disease
    Johansen, KL
    SEMINARS IN DIALYSIS, 2004, 17 (03) : 202 - 208
  • [34] Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy
    Diepeveen, SHA
    Verhoeven, GHWE
    van der Palen, J
    Dikkeschei, BLD
    van Tits, LJ
    Kolsters, G
    Offerman, JJG
    Bilo, HJG
    Stalenhoef, AFH
    NEPHRON CLINICAL PRACTICE, 2004, 98 (01): : C3 - C7
  • [35] Continuous renal replacement therapy for end-stage renal disease - The wearable artificial kidney (WAK)
    Gura, V
    Beizai, M
    Ezon, C
    Polaschegg, HD
    CARDIOVASCULAR DISORDERS IN HEMODIALYSIS, 2005, 149 : 325 - 333
  • [36] Survival prediction factors in end stage renal disease replacement therapy (RRT).
    Corte, CD
    Ortega, F
    Rebollo, P
    Baltar, J
    Alvarez, R
    Alvarez-Ude, F
    Badía, X
    Guederiaga, J
    Fonseca, AD
    Mejido, C
    Gorostidi, M
    Escalada, P
    Baños, M
    Grande, JA
    KIDNEY INTERNATIONAL, 1999, 55 (01) : 370 - 371
  • [37] Hormone replacement therapy in postmenopausal women with end-stage renal disease
    Andreoli, SP
    KIDNEY INTERNATIONAL, 2000, 57 (01) : 341 - 342
  • [39] Survival during renal replacement therapy for diabetic end-stage renal disease in Pima Indians
    Nelson, RG
    Hanson, RL
    Pettitt, DJ
    Knowler, WC
    Bennett, PH
    DIABETES CARE, 1996, 19 (12) : 1333 - 1337
  • [40] The use of sugammadex in end-stage renal failure with renal replacement therapy
    Binhas, M.
    Bouyoucef, A.
    Paul, M.
    d'Honneur, G.
    Plaud, B.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2012, 31 (12): : 972 - 973